Indegene

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE065X01017
NSEID: INDGN
BSEID: 544172
View on NSE | View on BSE

INR

475.60

10.75 (2.31%)

BSENSE

Jan 28

BSE+NSE Vol: 3.26 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Thyrocare Tech.

Metropolis Healt

Indegene

Dr Lal Pathlabs

Poly Medicure

Vijaya Diagnost.

Krsnaa Diagnost.

Vimta Labs

Syngene Intl.

Suven Life Scie.

Nephrocare Healt

Why is Indegene Ltd ?

Flat results in Sep 25

PAT(Q) At Rs 102.10 cr has Fallen at -6.2% (vs previous 4Q average)

Below par performance in long term as well as near term

Along with generating -20.64% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Indegene for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Indegene

-21.48%

-0.65

32.90%

Sensex

8.49%

0.76

11.24%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

19.50%

EBIT Growth (5y)

21.45%

EBIT to Interest (avg)

18.74

Debt to EBITDA (avg)

0.39

Net Debt to Equity (avg)

-0.40

Sales to Capital Employed (avg)

1.10

Tax Ratio

23.24%

Dividend Payout Ratio

11.78%

Pledged Shares

Institutional Holding

19.55%

ROCE (avg)

39.84%

ROE (avg)

15.56%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.03

EV to EBIT

21.27

EV to EBITDA

18.10

EV to Capital Employed

6.06

EV to Sales

3.42

PEG Ratio

Dividend Yield

0.42%

ROCE (Latest)

28.47%

ROE (Latest)

15.56%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

PAT(Latest six months)

At Rs 218.50 cr has Grown at 21.79%

NET SALES(Q)

Highest at Rs 804.20 cr

-2What is not working for the Company

PAT(Q)

At Rs 102.10 cr has Fallen at -6.2% (vs previous 4Q average

Loading Valuation Snapshot...

Here's what is working for Indegene

Net Sales - Quarterly

Highest at Rs 804.20 cr and Grown

each quarter in the last five quarters

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Here's what is not working for Indegene

Profit After Tax (PAT) - Quarterly

At Rs 102.10 cr has Fallen at -6.2% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 108.85 Cr

MOJO Watch

Near term PAT trend is negative

PAT (Rs Cr)